Are there patient assistance programs that make GLP-1 medications more affordable?

Yes. Manufacturers typically offer savings/assistance programs for patients without private drug insurance (for example, programs associated with Wegovy and Mounjaro/Zepbound), which can reduce out-of-pocket cost for eligible patients. Eligibility and the amount of savings vary, so checking directly with the specific manufacturer's program page or your pharmacist is the most reliable way to see what applies to your situation. References: https://obesitycanada.ca/healthcare-professionals/adult-clinical-practice-guideline/